Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2− Breast Cancer Based on a Window of Opportunity StudyAlberto D’Angelo, Daniele Generali, Robert Chapman et al.|Current Issues in Molecular Biology|2022Cited by 2